Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
7151
MediaAlpha
MAX
$808M
| $902K | ﹤0.01% |
91,592
+29,954
| +49% | +$365K |
|
|
MTBL
7152
PUT
DELISTED
Moatable, Inc. American Depositary Share (each representing forty-five (45) Class A Ordinary Shares)
MTBL
| $902K | ﹤0.01% |
312,000
-84,000
| -21% | -$231K |
|
7153
CALL
Gildan
GIL
$10.3B
| $901K | ﹤0.01% |
31,300
+22,600
| +260% | +$723K |
|
7154
Quanta Services
PWR
$105B
| $901K | ﹤0.01% |
7,189
-274,055
| -97% | -$33.6M |
|
7155
CALL
SELLAS Life Sciences
SLS
$2.65B
| $901K | ﹤0.01% |
403,900
+245,300
| +155% | +$719K |
|
7156
CALL
iShares Core Dividend Growth ETF
DGRO
$43.7B
| $900K | ﹤0.01% |
18,900
-8,700
| -32% | -$439K |
|
7157
Distillate US Fundamental Stability & Value ETF
DSTL
$2.06B
| $900K | ﹤0.01% |
23,245
+8,429
| +57% | +$353K |
|
|
GES
7158
DELISTED
Guess Inc
GES
| $900K | ﹤0.01% |
52,770
+13,027
| +33% | +$271K |
|
7159
CALL
WisdomTree Japan Hedged Equity Fund
DXJ
$7.24B
| $899K | ﹤0.01% |
+14,400
| New | +$917K |
|
7160
Fidelity MSCI Health Care Index ETF
FHLC
$3.44B
| $899K | ﹤0.01% |
+14,810
| New | +$919K |
|
7161
Oportun Financial
OPRT
$341M
| $899K | ﹤0.01% |
108,613
+28,645
| +36% | +$330K |
|
7162
CALL
Rhythm Pharmaceuticals
RYTM
$7.94B
| $899K | ﹤0.01% |
216,700
+21,400
| +11% | +$117K |
|
7163
CALL
indie Semiconductor
INDI
$917M
| $898K | ﹤0.01% |
157,500
-80,700
| -34% | -$556K |
|
7164
CALL
Ocugen
OCGN
$454M
| $898K | ﹤0.01% |
395,800
-270,900
| -41% | -$648K |
|
7165
Oric Pharmaceuticals
ORIC
$1.44B
| $898K | ﹤0.01% |
200,387
-30,300
| -13% | -$121K |
|
7166
Grupo Aeroportuario del Pacifico
PAC
$12.2B
| $898K | ﹤0.01% |
+6,434
| New | +$943K |
|
|
PMT
7167
PUT
PennyMac Mortgage Investment
PMT
$822M
| $898K | ﹤0.01% |
64,900
+34,100
| +111% | +$521K |
|
7168
PUT
Outdoor Holding Co
POWW
$262M
| $898K | ﹤0.01% |
233,200
-22,500
| -9% | -$93.5K |
|
7169
CALL
Atmos Energy
ATO
$28.8B
| $897K | ﹤0.01% |
8,000
-22,400
| -74% | -$2.57M |
|
|
CNH
7170
CALL
CNH Industrial
CNH
$16.1B
| $897K | ﹤0.01% |
77,400
-35,100
| -31% | -$500K |
|
7171
PUT
Brookfield Infrastructure Partners
BIP
$17.6B
| $896K | ﹤0.01% |
23,450
+8,900
| +61% | +$366K |
|
7172
CALL
Cerence
CRNC
$383M
| $896K | ﹤0.01% |
35,500
-181,500
| -84% | -$5.43M |
|
7173
Pembina Pipeline
PBA
$28.7B
| $896K | ﹤0.01% |
25,340
-127,984
| -83% | -$4.93M |
|
|
SJR
7174
DELISTED
Shaw Communications Inc.
SJR
| $896K | ﹤0.01% |
30,411
-24,415
| -45% | -$707K |
|
7175
CALL
Ameren
AEE
$30.4B
| $895K | ﹤0.01% |
9,900
-7,500
| -43% | -$694K |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.